Zai Lab and argenx Announce Approval of VYVGART® (efgartigimod alfa injection) for Generalized Myasthenia Gravis in China
First-and-only approved FcRn antagonist for gMG patients by NMPA 68% of anti-AChR antibody positive gMG…
First-and-only approved FcRn antagonist for gMG patients by NMPA 68% of anti-AChR antibody positive gMG…
TAIPEI--(BUSINESS WIRE)--PharmaEssentia Corporation (TPEx:6446), a leading fully integrated biopharmaceutical company in Taiwan, today announced the…
 Atlantic Lithium releases DFS for Ewoyaa Lithium Project Sayona Mining publishes preliminary technical study for…
ST. LOUIS--(BUSINESS WIRE)--Thompson Street Capital Partners (TSCP), a private equity firm based in St. Louis,…
HONG KONG SAR - Media OutReach - 30 June 2023 - Neurum Health ("Neurum"), a…
Partnership to offer comprehensive security platform for OT and address industrial segments BENGALURU, India--(BUSINESS WIRE)--$LTTS…
TOKUSHIMA, Japan--(BUSINESS WIRE)--Following to the previous information on May 15th in 2023 (Phase 3 Study…
Reservation agreeement signed 5 years exclusivity to develop Pooki project Development works to start in…
SINGAPORE - Media OutReach - 30 June 2023 - Durian sellers on Shopee recorded high…
HO CHI MINH CITY, VIETNAM - Media OutReach - 30 June 2023 - Blofin, the…